A novel application for murine double minute 2 antagonists: the p53 tumor suppressor network also controls angiogenesis.
Binder
Bernd R
BR
D020533:Angiogenesis Inhibitors / Q000494:pharmacology; D000818:Animals; D025461:Feedback, Physiological; D006706:Homeostasis; D007093:Imidazoles / Q000378:metabolism* / Q000494:pharmacology*; D009369:Neoplasms / Q000098:blood supply*; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D010879:Piperazines / Q000378:metabolism* / Q000494:pharmacology*; D051736:Proto-Oncogene Proteins c-mdm2 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000037:antagonists & inhibitors* / Q000378:metabolism
D020533:Angiogenesis Inhibitors; D007093:Imidazoles; D010879:Piperazines; D016159:Tumor Suppressor Protein p53; C482205:nutlin 3; C497207:Mdm2 protein, mouse; D051736:Proto-Oncogene Proteins c-mdm2